Zobrazeno 1 - 10
of 27
pro vyhledávání: '"G. van Esch"'
Autor:
Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://doaj.org/article/ae2985823b1043c281f9a4695715eadb
Autor:
Sjoerd H van der Burg, Ziena Abdulrahman, Noel de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Hans W Nijman, Marij J. P. Welters, Mariette I E van Poelgeest
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Vulvar high-grade squamous intraepithelial lesion (vHSIL) is predominantly induced by high-risk human papilloma virus type 16 (HPV16). In two independent trials, therapeutic vaccination against the HPV16 E6 and E7 oncoproteins resulted in
Externí odkaz:
https://doaj.org/article/0e0d2f0ef1a04f048f971b6ef0646463
Autor:
Ziena Abdulrahman, Natasja Hendriks, Arnold J Kruse, Antonios Somarakis, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Noel F C C de Miranda, Loes F S Kooreman, Brigitte F M Slangen, Sjoerd H van der Burg, Peggy J de Vos van Steenwijk, Edith M G van Esch
Publikováno v:
Journal for ImmunoTherapy of Cancer, 10(11). BMJ PUBLISHING GROUP
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
BackgroundThe complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Publikováno v:
Cancer Immunology, Immunotherapy. 70:1821-1829
Introduction Endometriosis is a risk factor for low-grade serous, clear cell, and endometroid ovarian carcinoma. In both endometriosis and ovarian carcinoma, immunological factors are associated with clinical outcome. Chronic inflammation in endometr
Autor:
Caroline L. P. Muntinga, Peggy J. de Vos van Steenwijk, Ruud L. M. Bekkers, Edith M. G. van Esch
Publikováno v:
Journal of Clinical Medicine, 11(5):1432. Multidisciplinary Digital Publishing Institute (MDPI)
Cervical high-grade squamous intraepithelial lesions (cHSILs) develop as a result of a persistent high-risk human papilloma virus (hrHPV) infection. The natural course of cHSIL is hard to predict, depending on a multitude of viral, clinical, and immu
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(7)
Endometriosis is a risk factor for low-grade serous, clear cell, and endometroid ovarian carcinoma. In both endometriosis and ovarian carcinoma, immunological factors are associated with clinical outcome. Chronic inflammation in endometriosis may be
Autor:
J Hanneke N G Oude Elberink, Marij J. P. Welters, Marjolein J. Kagie, Nikki M. Loof, Theo Stijnen, Linda F. M. Stynenbosch, Bart W. J. Hellebrekers, Marc van Beurden, Margriet J. G. Löwik, A. Rob P. M. Valentijn, Ineke E. Hamming, Sjoerd H. van der Burg, Tjalling Bosse, Henk W.R. Schreuder, Dorien M A Berends-van der Meer, Hans W. Nijman, Mariëtte I.E. van Poelgeest, Edith M G van Esch, Renee Vermeij, Gert Jan Fleuren, Toos Daemen, J. Baptist Trimbos, Cornelis J. M. Melief, Harry Hollema, Lorraine M. Fathers, Gemma G. Kenter, Jaap Oostendorp
Publikováno v:
Clinical cancer research, 22(10), 2342-2350. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(10), 2342-2350. AMER ASSOC CANCER RESEARCH
van Poelgeest, M I E, Welters, M J P, Vermeij, R, Stynenbosch, L F M, Loof, N M, Berends-van der Meer, D M A, Lowik, M J G, Hamming, I L E, van Esch, E M G, Hellebrekers, B W J, van Beurden, M, Schreuder, H W, Kagie, M J, Trimbos, J B M Z, Fathers, L M, Daemen, T, Hollema, H, Valentijn, A R P M, Oostendorp, J, Oude Elberink, H N G, Fleuren, G J, Bosse, T, Kenter, G G, Stijnen, T, Nijman, H W, Melief, C J M & van der Burg, S H 2016, ' Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response ', Clinical Cancer Research, vol. 22, no. 10, pp. 2342-2350 . https://doi.org/10.1158/1078-0432.CCR-15-2594
Clinical Cancer Research, 22(10), 2342. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(10), 2342-2350. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(10), 2342-2350. AMER ASSOC CANCER RESEARCH
van Poelgeest, M I E, Welters, M J P, Vermeij, R, Stynenbosch, L F M, Loof, N M, Berends-van der Meer, D M A, Lowik, M J G, Hamming, I L E, van Esch, E M G, Hellebrekers, B W J, van Beurden, M, Schreuder, H W, Kagie, M J, Trimbos, J B M Z, Fathers, L M, Daemen, T, Hollema, H, Valentijn, A R P M, Oostendorp, J, Oude Elberink, H N G, Fleuren, G J, Bosse, T, Kenter, G G, Stijnen, T, Nijman, H W, Melief, C J M & van der Burg, S H 2016, ' Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response ', Clinical Cancer Research, vol. 22, no. 10, pp. 2342-2350 . https://doi.org/10.1158/1078-0432.CCR-15-2594
Clinical Cancer Research, 22(10), 2342. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(10), 2342-2350. American Association for Cancer Research Inc.
Purpose: Therapeutic vaccination with human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides (SLP) is effective against HPV16-induced high-grade vulvar and vaginal intraepithelial neoplasia (VIN/VaIN). However, clinical nonresponders
Publikováno v:
The European Journal of Contraception & Reproductive Health Care. 17:170-174
Objectives Endometrial resection is a procedure often performed for treatment of menorrhagia. Despite the fact that amenorrhoea frequently ensues, some normal endometrium can remain present and become the implantation site of a pregnancy. Such an eve
Autor:
Maddy J. G. H. Smeets, E. M. G. van Esch, H. E. Schaafsma, S. E. van Wijngaarden, Johann P. T. Rhemrev
Publikováno v:
Archives of Gynecology and Obstetrics, 283, 1369-71
Archives of Gynecology and Obstetrics, 283, 6, pp. 1369-71
Archives of Gynecology and Obstetrics, 283, 6, pp. 1369-71
Item does not contain fulltext INTRODUCTION: A primary fibroid (leiomyoma) arising from both ovaries is rare and can be difficult to diagnose as a result of the low incidence and its indistinctive presentation. A literature review on the diagnostic a
Autor:
Edith M G, van Esch, Mariette I E, van Poelgeest, Simone, Kouwenberg, E Michelle, Osse, J Baptist M Z, Trimbos, Gert Jan, Fleuren, Ekaterina S, Jordanova, Sjoerd H, van der Burg
Publikováno v:
International journal of cancer. 136(4)
Human papillomavirus-induced usual-type vulvar intraepithelial neoplasia (uVIN) are infiltrated by immune cells but apparently not cleared. A potential explanation for this is an impaired T cell effector function by an immunesuppressive milieu, coinf